Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

Read the press release from here



HekaBio Completes Financing Round

HekaBio K.K. announced today that it has successfully completed a financing round of JPY 400 million. Proceeds will be used to strengthen and expand HekaBio’s portfolio of innovations in development i